Annotation Detail

Information
Associated Genes
EGFR
Associated Variants
EGFR AMPLIFICATION ( ENST00000275493.7 )
EGFR AMPLIFICATION ( ENST00000275493.7 )
Associated Disease
head and neck squamous cell carcinoma
Source Database
CIViC Evidence
Description
EGFR amplification was not a predictor of response to cetuximab/5-FU/platinum in patients with recurrent or metastatic HNSSC from the EXTREME study.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/691
Gene URL
https://civic.genome.wustl.edu/links/genes/19
Variant URL
https://civic.genome.wustl.edu/links/variants/190
Rating
4
Evidence Type
Predictive
Disease
Head And Neck Squamous Cell Carcinoma
Evidence Direction
Does Not Support
Drug
Fluorouracil,Platinum Compound,Cetuximab
Evidence Level
B
Clinical Significance
Sensitivity/Response
Pubmed
21048039
Drugs
Drug NameSensitivitySupported
CetuximabSensitivityfalse
FluorouracilSensitivityfalse
Platinum CompoundSensitivityfalse